drugset / Trial / NCT00641927

Antidepressant Therapy for Bipolar II Major Depression

NCT00641927

Phase 4 Completed 90 enrolled Stanley Medical Research Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

This study examines the relative safety and benefit of antidepressant therapy (versus recommended mood stabilizer therapy)of bipolar type II major depressive episode. We hypothesize that antidepressant therapy will be superior to mood stabilizer therapy with little or no difference in treatment emergent manic symptoms.

Timeline

Start
2002-04
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lithium Carbonate Unknown 300 mg
Comparator Lithium Carbonate Unknown 2100 mg
Subject Venlafaxine Small molecule 37.5 mg
Subject Venlafaxine Small molecule 375 mg

Indications